Skip to main content
. 2021 Apr 15;11(4):1304–1320.

Figure 6.

Figure 6

Decursin reduces the growth of patient-derived gastric cancer organoids (PDGOs) and inhibits autophagic flux. A. Hematoxylin and eosin staining of adjacent non-tumor and tumor tissues (×200). Scale bar: 100 μm. B. Representative images of organoids treated with decursin (×100). Scale bar: 100 μm. C. CTSC expression and autophagic flux were confirmed by western blotting in decursin-treated organoids. Full-length blots are presented in Supplementary Figure 6.